| Stock |
Weight |
Amount |
| Nps Pharmaceuticals |
3.71% |
$32,973,507 |
| Aegerion Pharmaceuticals In |
3.19% |
$28,395,793 |
| Vertex Pharmaceuticals |
3.09% |
$27,492,863 |
| Regeneron Pharmaceuticals |
3.06% |
$27,191,125 |
| Theravance |
3.05% |
$27,087,566 |
| Alkermes Plc |
2.80% |
$24,873,308 |
| Biogen Idec |
2.78% |
$24,743,651 |
| Myriad Genetics |
2.68% |
$23,871,798 |
| Gilead Sciences |
2.53% |
$22,484,775 |
| Sarepta Therapeutics |
2.48% |
$22,057,877 |
| Cubist Pharmaceuticals |
2.40% |
$21,339,948 |
| Isis Pharmaceuticals |
2.40% |
$21,384,456 |
| Seattle Genetics |
2.34% |
$20,817,374 |
| Amgen |
2.33% |
$20,746,019 |
| Alexion Pharmaceuticals |
2.29% |
$20,326,518 |
| Celgene |
2.29% |
$20,324,884 |
| United Therapeutics Corp De |
2.27% |
$20,174,693 |
| Onyx Pharmaceuticals |
2.23% |
$19,863,088 |
| Biomarin Pharmaceutical |
2.21% |
$19,610,795 |
| Immunogen |
2.20% |
$19,569,419 |
| Page 1 2 3 next » |
|
